Related references
Note: Only part of the references are listed.Results of genetic analysis of 11 341 participants enrolled in the My Life, Our Future hemophilia genotyping initiative in the United States
Jill M. Johnsen et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)
NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data
Birkir Reynisson et al.
NUCLEIC ACIDS RESEARCH (2020)
The prospective Hemophilia Inhibitor PUP Study reveals distinct antibody signatures prior to FVIII inhibitor development
B. M. Reipert et al.
BLOOD ADVANCES (2020)
FVIII Protein Is Not Detectable in Human PBMCs or Livers from Dogs with an Intron-22 Inversion Mutation: Implications for FVIII Immunogenicity and Tolerance
Devi Gunasekera et al.
BLOOD (2019)
FVIII proteins with a modified immunodominant T-cell epitope exhibit reduced immunogenicity and normal FVIII activity
Ruth A. Ettinger et al.
BLOOD ADVANCES (2018)
Limit of detection and threshold for positivity of the Centers for Disease Control and Prevention assay for factor VIII inhibitors
C. H. Miller et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
T cells from hemophilia A subjects recognize the same HLA-restricted FVIII epitope with a narrow TCR repertoire
Ruth A. Ettinger et al.
BLOOD (2016)
Factor VIII gene variants and inhibitor risk in African American hemophilia A patients
Devi Gunasekera et al.
BLOOD (2015)
One-stage vs. chromogenic assays in haemophilia A
Joachim J. Potgieter et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2015)
The intron-22-inverted F8 locus permits factor VIII synthesis: explanation for low inhibitor risk and a role for pharmacogenomics
Zuben E. Sauna et al.
BLOOD (2015)
Six Amino Acid Residues in a 1200 Å2 Interface Mediate Binding of Factor VIII to an IgG4κ Inhibitory Antibody
Jasper C. Lin et al.
PLOS ONE (2015)
Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study
Samantha C. Gouw et al.
BLOOD (2013)
The CDC Hemophilia A Mutation Project (CHAMP) Mutation List: A New Online Resource
Amanda B. Payne et al.
HUMAN MUTATION (2013)
Endogenous factor VIII synthesis from the intron 22-inverted F8 locus may modulate the immunogenicity of replacement therapy for hemophilia A
Gouri Shankar Pandey et al.
NATURE MEDICINE (2013)
Detection of Intracellular Factor VIII Protein in Peripheral Blood Mononuclear Cells by Flow Cytometry
Gouri Shankar Pandey et al.
BIOMED RESEARCH INTERNATIONAL (2013)
F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis
Samantha C. Gouw et al.
BLOOD (2012)
Predictions versus high-throughput experiments in T-cell epitope discovery: competition or synergy?
Claus Lundegaard et al.
EXPERT REVIEW OF VACCINES (2012)
T-cell responses in two unrelated hemophilia A inhibitor subjects include an epitope at the factor VIII R593C missense site
E. A. James et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Peptide binding predictions for HLA DR, DP and DQ molecules
Peng Wang et al.
BMC BIOINFORMATICS (2010)
HLA-DR-restricted T-cell responses to factor VIII epitopes in a mild haemophilia A family with missense substitution A2201P
R. A. Ettinger et al.
HAEMOPHILIA (2010)
Lineages of human T-cell clones, including T helper 17/T helper 1 cells, isolated at different stages of anti-factor VIII immune responses
Ruth A. Ettinger et al.
BLOOD (2009)
Discordant antibody response in monozygotic twins with severe haemophilia A caused by intensive treatment
S. C. Gouw et al.
HAEMOPHILIA (2009)
Risk factors for inhibitor formation in haemophilia: a prevalent case-control study
M. V. Ragni et al.
HAEMOPHILIA (2009)
The Multifactorial Etiology of Inhibitor Development in Hemophilia: Genetics and Environment
Samantha C. Gouw et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2009)
A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach
Peng Wang et al.
PLOS COMPUTATIONAL BIOLOGY (2008)
T-cell responses over time in a mild hemophilia A inhibitor subject: epitope identification and transient immunogenicity of the corresponding self-peptide
E. A. James et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Epitope repertoire of human CD4+ T cells on the A3 domain of coagulation factor VIII
MT Reding et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
T cell recognition of the A2 domain of coagulation factor VIII in hemophilia patients and healthy subjects
GL Hu et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Recognition of coagulation factor VIII by CD4+ T cells of healthy humans
GL Hu et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
Human CD4+ T-cell epitope repertoire on the C2 domain of coagulation factor VIII
MT Reding et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
CD4+ T-cell clones specific for wild-type factor VIII:: a molecular mechanism responsible for a higher incidence of inhibitor formation in mild/moderate hemophilia A
M Jacquemin et al.
BLOOD (2003)
The Malmo International Brother Study (MIBS): further support for genetic predisposition to inhibitor development
J Astermark et al.
HAEMOPHILIA (2001)
Share Paper
